Kim, N., Pulte, E. D., Ehrlich, L. A., Ionan, A. C., Haupert, S., Vallejo, J., Green, F., Zheng, N., Wang, Y., Liu, J., Blanco, J. G., Dorff, S. E., Booth, B., Choe, M., Gehrke, B., Bhatnagar, V., Theoret, M., Pazdur, R., Claro, R. A. D., Norsworthy, K. J. (2025). US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01369